Michael Milliken

Michael Milliken

Auto-generated profile, based on publicly available information

Michael Milliken

School of Medicine

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
SBSophie Belman
Sophie Belman
JWJessica A. Walsh
Jessica A. Walsh
CCCourtney Carroll
Courtney Carroll
MMMichael Milliken
Michael Milliken
BHBenjamin Haaland
Benjamin Haaland
BFBingjian Feng
Bingjian Feng
Objective.: Delays in the diagnosis and treatment of psoriatic arthritis (PsA) are common. These delays contribute to impairments in quality of life and joint damage. This study aims to calculate the incidence rate of PsA over time and identify clinical features that may be used for PsA prediction in patients with psoriasis (PsO).Methods.: The study population for PsA incidence analysis included 1128 participants enrolled in the Utah Psoriasis Initiative between 2002 and 2014. Clinical evaluation and medical record review were performed to identify new cases of PsA after enrollment. To identify PsO features associated with PsA, the population was restricted to 627 participants who did not have PsA before PsO phenotyping and had been followed up for subsequent PsA diagnosis. We conducted Cox proportional hazard regressions to estimate the HR of PsA associated with PsO characteristics and other health-related features.Results.: PsA incidence rate increased for > 60 years following PsO onset (trend P < 0.0001). There was a significant association between PsA and induration severity in untreated lesions (P < 0.001, HR 1.46), history of fingernail involvement (P < 0.001, HR 2.38), pustular PsO (P < 0.001, HR 3.32), fingernail involvement at enrollment (P < 0.001, HR 2.04), and Koebner phenomenon (P < 0.001, HR 1.90). Multivariate analysis yielded a model that included a history of fingernail involvement (P < 0.001, HR 2.16) and untreated induration (P < 0.001, HR 1.41).Conclusion.: Risk of PsA increases steadily for > 60 years following PsO onset. Patient-reported history of PsO characteristics has greater predictive power than physician-measured features at enrollment visits. The characteristics identified in this study provide guidance for screening for PsA risk in patients with PsO.

1 May 2016 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
MMMichael Milliken
Michael Milliken
EGElena Generali
Elena Generali
JMJosefina Marin
Josefina Marin
CRChristopher T. Ritchlin
Christopher T. Ritchlin
At the 2015 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, rheumatology and dermatology trainees engaged in psoriasis or psoriatic arthritis research presented their work to meeting attendees in a trainees symposium. This report briefly reviews 6 oral presentations and 20 posters presented at the meeting.


8 July 2026
Verified
Book Chapter
Closed access
PDF file
MMMichael Milliken
Michael Milliken
FAFaris Alhomida
Faris Alhomida